| Browse All

Franklin Genomic Advancements ETF (HELX)

Health | Exchange Traded Fund | Cboe US
34.02 USD
Short-term: ★★☆☆☆ | Long-term: ★★★☆☆ | Dividends: ★★☆☆☆
Hot Take | April 11, 2026, 2:56 p.m. EDT

HELX has shown mixed short-term price movements, with recent volatility and a slight downward trend. The dividend yield is moderate, but the dividend history is inconsistent, which affects the dividend star rating. While the options data suggests some bullish sentiment for higher prices, the lack of significant put activity indicates limited bearish speculation. Long-term investors might consider the recent dip as a potential buying opportunity, but the fundamentals and dividend reliability are not strong enough to warrant a high rating.
Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoARIMA ✓0.078446
AutoETS0.078941
AutoTheta0.080496
MSTL0.084857

Forecast horizon: 45 days | Selected: AutoARIMA

Forecast Reliability
Score 44%
H-stat 9.18
Ljung-Box p 0.000
Jarque-Bera p 0.278
Excess Kurtosis -0.62
Attribute Value
Trailing P/E 29.61

As of April 11, 2026, 2:56 p.m. EDT: The options activity indicates a lack of significant positioning, with minimal volume and open interest. The calls for May 15 and August 21 show some interest in strikes above the current price, suggesting a potential bullish sentiment for higher prices. However, the low volume and open interest suggest limited speculative activity. The high IV for the August 21 calls might indicate increased volatility expectations, but the lack of put activity suggests limited bearish sentiment.

Dividend Data

Yield Summary
Last Yield 1yr Yield 3yr Avg 5yr Avg
0.39% 0.39% 0.13% 0.13%
Dividend History
Date Dividend Yield %
2025-12-30 0.143 0.393452
2021-12-30 0.004 0.008265
2021-12-13 0.114 0.241455
2020-12-14 0.052 0.119994
Additional Data
trailingAnnualDividendRate 0.0
trailingAnnualDividendYield 0.0
dividendYield 0.43

Info Dump

Attribute Value
All Time High 58.61
All Time Low 18.41
Ask 34.87
Ask Size 200
Average Daily Volume10 Day 1,150
Average Daily Volume3 Month 1,021
Average Volume 1,021
Average Volume10Days 1,150
Beta3 Year 1.2
Bid 34.73
Bid Size 100
Category Health
Crypto Tradeable 0
Currency USD
Custom Price Alert Confidence HIGH
Day High 34.1419
Day Low 34.0248
Dividend Yield 0.43
Eps Trailing Twelve Months 1.1492337
Esg Populated 0
Exchange BTS
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 33.5907
Fifty Day Average Change 0.4341011
Fifty Day Average Change Percent 0.012923254
Fifty Two Week Change Percent 33.793404
Fifty Two Week High 38.17
Fifty Two Week High Change -4.145199
Fifty Two Week High Change Percent -0.10859835
Fifty Two Week Low 24.94
Fifty Two Week Low Change 9.084799
Fifty Two Week Low Change Percent 0.3642662
Fifty Two Week Range 24.94 - 38.17
First Trade Date Milliseconds 1,582,813,800,000
Five Year Average Return -0.0535018
Full Exchange Name Cboe US
Fund Family Franklin Templeton Investments
Fund Inception Date 1,582,588,800
Gmt Off Set Milliseconds -14,400,000
Has Pre Post Market Data 1
Language en-US
Legal Type Exchange Traded Fund
Long Business Summary Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
Long Name Franklin Genomic Advancements ETF
Market us_market
Market State REGULAR
Max Age 86,400
Message Board Id finmb_641524305
Nav Price 34.01651
Net Assets 21,447,080.0
Net Expense Ratio 0.5
Open 34.1419
Previous Close 34.0248
Price Hint 2
Quote Source Name Nasdaq Real Time Price
Quote Type ETF
Region US
Regular Market Change 0.0
Regular Market Change Percent 0.0
Regular Market Day High 34.1419
Regular Market Day Low 34.0248
Regular Market Day Range 34.0248 - 34.1419
Regular Market Open 34.1419
Regular Market Previous Close 34.0248
Regular Market Price 34.0248
Regular Market Time 1,776,433,564
Regular Market Volume 107
Short Name Franklin Genomic Advancements E
Source Interval 15
Symbol HELX
Three Year Average Return 0.030797701
Total Assets 21,447,080
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing P E 29.60651
Trailing Peg Ratio None
Trailing Three Month Nav Returns -9.06849
Trailing Three Month Returns -9.06849
Triggerable 1
Two Hundred Day Average 33.094505
Two Hundred Day Average Change 0.93029404
Two Hundred Day Average Change Percent 0.028110227
Type Disp ETF
Volume 107
Yield 0.0043
Ytd Return -9.06849